34.71 USD
↘ 0.78 (2.20%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
34.75
↗ 0.04 (0.10%)
POST MARKET (AS OF 04:16 PM EDT)
Post Market
AS OF 04:16 PM EDT
34.75
↗ 0.04 (0.10%)
Market: CLOSED
Open?$35.44
High?$36.07
Low?$33.68
Prev. Close?$35.49
Volume?1.1M
Avg. Volume?705.6K
VWAP?$34.25
Rel. Volume?1.53x
Bid / Ask
Bid?$30.00 × 100
Ask?$35.85 × 400
Spread?$5.85
Midpoint?$32.93
Valuation & Ratios
Market Cap?2.1B
Shares Out?60.9M
Float?45.4M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?4.66
EPS?-$1.62
Dividend?0.00%
Ex-Dividend?N/A
ELVN is currently priced at $34.71. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, ELVN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
61
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
6200 LOOKOUT ROAD
BOULDER, CO 80301
Phone: 720-647-8519
BOULDER, CO 80301
Phone: 720-647-8519
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?109.65Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?11.29%High
Short Interest?5.1M
Days to Cover?8.1
Free Float45.4M
Avg Daily Volume636.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?40.32Strong
Quick Ratio?40.32Strong
Cash Ratio?11.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.66FAIR▾
Peers100
S&P39
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-17.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.8%WEAK▾
S&P7
ROA?-21.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-65603000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day